CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
229 hedge funds and large institutions have $2.8B invested in Clovis Oncology, Inc. in 2017 Q1 according to their latest regulatory filings, with 86 funds opening new positions, 77 increasing their positions, 55 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
36% more call options, than puts
Call options by funds: $100M | Put options by funds: $73.6M
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
Holders
229
Holding in Top 10
8
Calls
$100M
Puts
$73.6M
Top Buyers
| 1 | +$194M | |
| 2 | +$84.5M | |
| 3 | +$84M | |
| 4 |
D.E. Shaw & Co
New York
|
+$58.7M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$51.8M |
Top Sellers
| 1 | -$88.9M | |
| 2 | -$73M | |
| 3 | -$50.6M | |
| 4 |
SC
Samlyn Capital
New York
|
-$42M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
-$41.2M |